Blood And Lymphatic Cancer-targets And Therapy: Impact Factor, Indexing, Publication Time & Fees


The Blood And Lymphatic Cancer-targets And Therapy is reputed journal publishes research related to . The ISSN of the journal is 1179-9889.

Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.

Blood And Lymphatic Cancer-targets And Therapy: Details

Journal TitleBLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY
PublisherDOVE MEDICAL PRESS LTD
Publication CountryPO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752
ISSN1179-9889
Publication AreaOncology
Publication LanguageEnglish
Review Process
Scopus IndexedNo

Blood And Lymphatic Cancer-targets And Therapy Impact Factor

The Impact Factor of Blood And Lymphatic Cancer-targets And Therapy in 2026 is 3.9.

Indexing

The Blood And Lymphatic Cancer-targets And Therapy is indexed in: Web of Science, UGC CARE Group 2.



Similiar journals to publish


Blood and Lymphatic Cancer: Targets and Therapy
ISSN: 1179-9889
Publisher: Dove Press
Journal Scope: lymphoma, anticancer agents, haematology, leukaemia

BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY
ISSN: 1179-9889
Publisher: DOVE MEDICAL PRESS LTD
Journal Scope:

Breast Cancer: Targets and Therapy
ISSN: 11791314
Publisher: Dove Medical Press Ltd.
Journal Scope: Medicine

Lung Cancer: Targets and Therapy
ISSN: 1179-2728
Publisher: Dove Press
Journal Scope: Medicine

LUNG CANCER-TARGETS AND THERAPY
ISSN: 1179-2728
Publisher: DOVE MEDICAL PRESS LTD
Journal Scope:

BREAST CANCER-TARGETS AND THERAPY
ISSN: 1179-1314
Publisher: DOVE MEDICAL PRESS LTD
Journal Scope: